Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janette Walde

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
European Journal of Neurology|January 25, 2023
Sexual dysfunction in female and male people with multiple sclerosis: disability, depression and hormonal status matterFranziska Di Pauli, Anne Zinganell, Bettina Böttcher, et al.
Clinical Chemistry and Laboratory Medicine|May 28, 2025
Effect of long-term frozen storage on stability of kappa free light chain indexMartin Schmidauer, Klaus Berek, Gabriel Bsteh, et al.
Clinical Chemistry and Laboratory Medicine|April 19, 2025
Impact of renal function impairment on kappa free light chain indexMartin Schmidauer, Fabian Föttinger, Klaus Berek, et al.
European Journal of Neurology|April 5, 2025
Reactive Pleocytosis After Repeated Lumbar Puncture-Implications for Clinical PracticeMartin Schmidauer, Fabian Föttinger, Klaus Berek, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 29, 2021
Kappa-Free Light Chains in CSF Predict Early Multiple Sclerosis Disease ActivityKlaus Berek, Gabriel Bsteh, Michael Auer, et al.
Journal of Neurology|April 9, 2026
The role of age in choosing high-efficacy treatment for multiple sclerosis: an Austrian MS Database studyHarald Hegen, Fabian Föttinger, Janette Walde, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 1, 2022
Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A systematic review and meta-analysisHarald Hegen, Janette Walde, Klaus Berek, et al.
European Journal of Neurology|April 30, 2025
Short-Term Risk Factors for Bone Loss in Multiple Sclerosis: A Prospective Study and Literature ReviewAnne Zinganell, Harald Hegen, Janette Walde, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 16, 2025
Kappa free light chain index predicts long-term disease activity and disability accrual in multiple sclerosisKlaus Berek, Martin Schmidauer, Gabriel Bsteh, et al.
Ebiomedicine|April 22, 2023
Kappa free light chain and neurofilament light independently predict early multiple sclerosis disease activity-a cohort studyHarald Hegen, Klaus Berek, Gabriel Bsteh, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
European Journal of Neurology|January 25, 2023
Sexual dysfunction in female and male people with multiple sclerosis: disability, depression and hormonal status matterFranziska Di Pauli, Anne Zinganell, Bettina Böttcher, et al.
Clinical Chemistry and Laboratory Medicine|May 28, 2025
Effect of long-term frozen storage on stability of kappa free light chain indexMartin Schmidauer, Klaus Berek, Gabriel Bsteh, et al.
Clinical Chemistry and Laboratory Medicine|April 19, 2025
Impact of renal function impairment on kappa free light chain indexMartin Schmidauer, Fabian Föttinger, Klaus Berek, et al.
European Journal of Neurology|April 5, 2025
Reactive Pleocytosis After Repeated Lumbar Puncture-Implications for Clinical PracticeMartin Schmidauer, Fabian Föttinger, Klaus Berek, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 29, 2021
Kappa-Free Light Chains in CSF Predict Early Multiple Sclerosis Disease ActivityKlaus Berek, Gabriel Bsteh, Michael Auer, et al.
Journal of Neurology|April 9, 2026
The role of age in choosing high-efficacy treatment for multiple sclerosis: an Austrian MS Database studyHarald Hegen, Fabian Föttinger, Janette Walde, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 1, 2022
Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A systematic review and meta-analysisHarald Hegen, Janette Walde, Klaus Berek, et al.
European Journal of Neurology|April 30, 2025
Short-Term Risk Factors for Bone Loss in Multiple Sclerosis: A Prospective Study and Literature ReviewAnne Zinganell, Harald Hegen, Janette Walde, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 16, 2025
Kappa free light chain index predicts long-term disease activity and disability accrual in multiple sclerosisKlaus Berek, Martin Schmidauer, Gabriel Bsteh, et al.
Ebiomedicine|April 22, 2023
Kappa free light chain and neurofilament light independently predict early multiple sclerosis disease activity-a cohort studyHarald Hegen, Klaus Berek, Gabriel Bsteh, et al.
Pageof 4